+1-888-308-5802     

India readies 5 sites for Phase 3 Oxford-AstraZeneca vaccine trial

Author : Saipriya Iyer | Published Date : 2020-07-29 

Phase 3 or late-stage clinical trial of the Oxford-AstraZeneca coronavirus vaccine is reportedly set to be conducted across 5 sites in India.

Additionally, Oxford and its partner, AstraZeneca, have chosen the Serum Institute of India to manufacture the COVID-19 vaccine, following the anticipated achievement of positive trial results. The data from the Phase 1 and 2 trials has already been published earlier in July.

As per reports, the DBT (Department of Biotechnology) plays a key role in vaccine development, including funding, facilitating regulatory clearances, and providing access to various networks in the country. Moreover, the Serum Institute of India (SSI) based in Pune has sought permission from the DCGI (Drugs Controller General of India) to conduct the Phase 2 and 3 clinical trials. The institute is planning to commence the manufacturing process of the potential vaccine prior to achieving the final results, in order to ensure wide availability with sizable volumes once it receives overall approvals.

Earlier on 20th July, scientists announced high safety and efficacy of the vaccine developed by the Oxford University, as it induced a strong immune response in the Phase 1 trial. The doses of the vaccine were offered to 1,077 healthy subjects between 18-55 years of age, at 5 hospitals in the UK.

According to the results from this 1st phase, the vaccine candidate has induced a strong antibody as well as T-cell immune responses for over 56 days. The T-cells can significantly safeguard people against the virus for several years. Scientists also have discovered that the immune response could be higher after the patient receives the 2nd dose.

The Phase 1 vaccine trial was conducted among a small group of people to examine its safety as well as the stimulation of the immune system. In the 2nd phase, children and the elderly were studied to evaluate its safety and immunogenicity. The vaccine was then administered to a large number of subjects in the 3rd phase.

Source credit:

https://www.livemint.com/news/india/india-readies-5-sites-for-final-phase-of-human-trials-of-oxford-covid-19-vaccine-11595868711131.html

About Author

Saipriya Iyer

Saipriya Iyer

Saipriya Iyer presently works as a content developer for fractovia.org. Having dabbled with the domain of content creation for nearly half a decade, she now boasts of an enviable portfolio, holding substantial experience in penning down pieces related to technology, finance, and a wide spectrum of other industry verticals. A qualified computer engineering graduate from the University of Pune, Saipriya can often be found leveraging her knowledge of software technology and electronics in her write-ups. She can be contacted at- [email protected] | https://twitter.com/saipriya_i

Related News

Ramping production of lithium-ion batteries to accelerate tert-amylbenzene demand in Asia Pacific

Published Date: 2021-01-05         Author: Saipriya Iyer

As an active pharmaceutical ingredient (API) used in various clinical products to being used as an electronic additive in the making of lithium-ion batteries, tert amylbenzene (TAB) has gained wide-spread recognition across diverse industries. The chemical substance acts as a crucial intermediate in... Read More

FMCG firms to explore oral care market amidst rising hygiene concerns

Published Date: 2021-01-04         Author: Saipriya Iyer

Fast-moving consumer goods businesses in India are reportedly expanding their range of oral care, joining new and niche categories including mouthwashes, ayurvedic mouth cleansers, and mouth sprays as customer issues around general hygiene persists. For the record, Dabur India and Colgate Palmoli... Read More

Microsoft to introduce ‘Google assistant’ alternative for Windows

Published Date: 2020-12-28         Author: Saipriya Iyer

Microsoft Corporation, an American multinational technology giant, is reportedly testing a new voice launcher feature which will enable users to interact with files and applications using voice commands. According to trusted sources, the feature is currently available to select group of users who... Read More

© 2021 Fractovia. All Rights Reserved